The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics

Status Completed

Clinical Trial Summary

The aim of this clinical trial is to evaluate the ratio of hypnotic to analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using SPI and EEG analysis.

Clinical Trial Description

Anesthetic agents vary in their relative hypnotic potency. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetic agents may produce different spectral entropy or bispectral index values. However, there is no study that demonstrate the difference between analgesic potency of volatile anesthetics. The aim of this clinical trial is to evaluate the ratio of hypnotic to analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using SPI and EEG analysis. ;

Study Design

Related Conditions & MeSH terms

Anesthesia, General

Clinical Trial Details

NCT number	NCT02698514
Study type	Interventional
Source	Kangbuk Samsung Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	February 16, 2016
Completion date	July 13, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063798` - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery	N/A
Not yet recruiting	`NCT05035069` - Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR	Phase 4
Completed	`NCT03861364` - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose.	Phase 4
Completed	`NCT02711280` - The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children	N/A
Completed	`NCT01199471` - Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane	N/A
Completed	`NCT00917033` - Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy	Phase 4
Completed	`NCT00391885` - Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy	Phase 4
Completed	`NCT00552617` - A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)	Phase 2
Completed	`NCT03705026` - Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
Completed	`NCT00552929` - A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974)	Phase 2
Completed	`NCT00298831` - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)	Phase 3
Completed	`NCT00475215` - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)	Phase 3
Recruiting	`NCT03943745` - EEG Changes During Induction of Propofol Anesthesia
Completed	`NCT03697642` - Nasopharyngeal Airway Guide Nasogastric Tube Placement	N/A
Completed	`NCT04595591` - Observation of Propofol Titration at Different Speeds	N/A
Not yet recruiting	`NCT05841316` - The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
Completed	`NCT04532502` - Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
Completed	`NCT03330236` - EEG - Guided Anesthetic Care and Postoperative Delirium	N/A
Recruiting	`NCT06205212` - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis	N/A
Completed	`NCT00379613` - Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)	Phase 2